FR2708283B1 - Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives. - Google Patents

Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives.

Info

Publication number
FR2708283B1
FR2708283B1 FR9400352A FR9400352A FR2708283B1 FR 2708283 B1 FR2708283 B1 FR 2708283B1 FR 9400352 A FR9400352 A FR 9400352A FR 9400352 A FR9400352 A FR 9400352A FR 2708283 B1 FR2708283 B1 FR 2708283B1
Authority
FR
France
Prior art keywords
treatment
pharmaceutical compositions
neurodegenerative diseases
neurodegenerative
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9400352A
Other languages
English (en)
Other versions
FR2708283A1 (fr
Inventor
Mallet Jacques
Revah Frederic
Robert Jean-Jacques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9400352A priority Critical patent/FR2708283B1/fr
Publication of FR2708283A1 publication Critical patent/FR2708283A1/fr
Application granted granted Critical
Publication of FR2708283B1 publication Critical patent/FR2708283B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR9400352A 1994-01-14 1994-01-14 Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives. Expired - Lifetime FR2708283B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9400352A FR2708283B1 (fr) 1994-01-14 1994-01-14 Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9400352A FR2708283B1 (fr) 1994-01-14 1994-01-14 Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives.

Publications (2)

Publication Number Publication Date
FR2708283A1 FR2708283A1 (fr) 1995-02-03
FR2708283B1 true FR2708283B1 (fr) 1995-10-20

Family

ID=9459029

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9400352A Expired - Lifetime FR2708283B1 (fr) 1994-01-14 1994-01-14 Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives.

Country Status (1)

Country Link
FR (1) FR2708283B1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707880B1 (fr) * 1993-06-30 1995-10-06 Rhone Poulenc Rorer Sa Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9114437D0 (en) * 1991-07-03 1991-08-21 Health Lab Service Board Recombinant adenoviruses and the use thereof for detecting the presence in eukaryotic cells of the expression products of specific genes

Also Published As

Publication number Publication date
FR2708283A1 (fr) 1995-02-03

Similar Documents

Publication Publication Date Title
NL300258I2 (nl) Farmaceutische samenstelling voor toepassing in debehandeling van.
MA26420A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de l'osteoporose, et procede pour leur preparation.
FR2754713B1 (fr) Utilisation de complexes pour la preparation de compositions pour le traitement des peaux sensibles, procede de preparation et compositions hypoallergeniques
BE875634A (fr) Compositions pharmaceutiques et leur utilisation pour le traitement prophylactique et therapeutique de l'hyperplasie de la prostate
FR12C0077I2 (fr) Composition pour le traitement des condylomes génitaux
TR199901172T2 (xx) Yeni ikame edilmi� pirazol t�revleri.
MA26508A1 (fr) Formulations pharmaceutiques contenant du variconazole, et procede pour leur preparation.
NZ332721A (en) Use of bactericidal/permeability increasing (BPI) protein sometimes in conjunction with a thrombolytic agent to treat thrombotic disorders
FR2745016B1 (fr) Composition pour une lotion adoucissante, utilisation de la lotion pour le traitement d'un produit papetier absorbant et produit papetier absorbant ainsi traite
PL323490A1 (en) Tetralinic compounds exibiting acitity against multgiple-drug refractoriness
LV11666A (lv) Farmaceitiskie preparati un medikamenti endotelialo traucejumu noversanai un arstesanai
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ZA968990B (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
ZA97741B (en) Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders.
DE3850433D1 (de) Allergiebehandlung und Zusammensetzung dafür.
IL115589A0 (en) Use of cck-b antagonists in pharmaceutical compositions
FR2717080B1 (fr) Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
MA26650A1 (fr) Oxo-thia -azabicyclooctenes, preparations pharmaceutiques les contenant, et leur utilisation pour le traitement et la prophylaxie de maladies infectieuses.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ATE254595T1 (de) 2-amino-6-methyl-7-acetyl-tetralin und pharmazeutische zusammensetzungen zur vorbeugung und therapeutischen behandlung von entzündlichen und/oder autoimmunkrankheiten
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
AU5963396A (en) Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
FR2708283B1 (fr) Compositions pharmaceutiques et leur utilisation, notamment pour le traitement des maladies neurodégénératives.
MA26652A1 (fr) Compositions pharmaceutiques mixtes pour le traitement de la faiblesse musculosquelettique, et procede pour leur preparation

Legal Events

Date Code Title Description
CD Change of name or company name